Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 44,521 | 37,868 | 39,553 | 42,011 | 35,985 |
| Cost of Goods | 6,667 | 6,586 | 6,067 | 9,119 | 8,811 |
| Gross Profit | 37,854 | 31,282 | 33,486 | 32,892 | 27,174 |
| Operating Expenses | 41,313 | 38,300 | 43,107 | 38,716 | 35,663 |
| Operating Income | -2,792 | -6,432 | -9,555 | -5,705 | -7,677 |
| Interest Expense | 496 | 606 | 668 | 586 | 98 |
| Other Income | 464 | 572 | 3,938 | 710 | 2,213 |
| Pre-tax Income | -2,824 | -6,466 | -6,285 | -5,581 | -5,562 |
| Income Tax | 40 | -23 | 46 | 69 | 35 |
| Net Income Continuous | -2,865 | -6,444 | -6,331 | -5,650 | -5,597 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 1,994 |
| Minority Interests | -29 | 36 | -51 | -80 | -95 |
| Net Income | $-2,836 | $-6,480 | $-6,279 | $-5,570 | $-3,508 |
| EPS Basic Total Ops | -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
| EPS Basic Continuous Ops | -0.19 | -0.46 | -0.44 | -0.39 | -0.37 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.13 |
| EPS Diluted Total Ops | -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
| EPS Diluted Continuous Ops | -0.19 | -0.46 | -0.44 | -0.39 | -0.37 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.13 |
| EPS Diluted Before Non-Recurring Items | 0.07 | -0.09 | 0.14 | 0.11 | -0.01 |
| EBITDA(a) | $1,353 | $-1,530 | $-1,275 | $-377 | $-3,071 |